average weight loss per month on glp 1 Expected for Semaglutide GLP-1 Medications The UK's Complete Guide to

Not sure which of these protocols fits you

Stop medication immediately if: Persistent vomiting (more than 3 episodes per day for more than 3 days) Inability to keep down liquids Unintentional weight loss exceeding 2% of body weight per week Signs of dehydration (dark urine, dizziness, reduced urination) Severe abdominal pain Vomiting blood or coffee-ground material Consider dose reduction (rather than stopping) if: Mild to moderate nausea that improves between doses Early satiety but able to maintain nutrition with smaller meals Symptoms that started or worsened with recent dose escalation Weight loss goals are being met and you want to continue treatment Continue current dose with dietary modification if: Mild intermittent nausea Bloating or fullness that resolves within 2-3 hours after meals Symptoms present but not interfering with daily activities No weight loss beyond expected The dose-reduction protocol: If reducing dose rather than stopping: Drop to the previous tolerated dose (if you're at 2 mg semaglutide and symptoms started after escalation from 1 mg, return to 1 mg) Stay at reduced dose for 4 to 6 weeks to assess symptom improvement If symptoms resolve, continue at that dose indefinitely If symptoms persist at reduced dose, discontinue entirely About 40% of patients with mild gastroparesis symptoms can continue treatment at a reduced dose without progression to severe gastroparesis (Acosta et al., Clinical Gastroenterology and Hepatology , 2024)

While retatrutide has produced impressive results in early studies, those studies were not direct head-to-head comparisons with semaglutide or tirzepatide

GLP-1 is a naturally occurring hormone that regulates appetite and promotes fullness

Secure data management : Ensuring personal health data is handled securely and in compliance with regulations such as HIPAA to maintain the highest standards of privacy and security

Bo qun: Ni kh ro thong mt